PAX6 and non-small cell lung carcinoma: In addition, Zhang et al. found that the methylation level of PAX6 in non-small cell lung cancer tissues was higher than that in normal tissues and that the methylation status of PAX6 was associated with a poor overall survival rate in cancer tissues.